Published: 21 February, 2017 | Volume 1 - Issue 1 | Pages: 001-011
Figure 7:
The binding ability of anti-VP2 scFvs to different IBDV strains by Elisa. The plates were coated with 300μg/mL scFvs, followed by incubation with different IBDV strains (include I-65, MB, BJ-836, NF-8, GT, B-87), chicken egg yolk antibody and secondary antibody. control1 (without VP2 or IBDV strains), control2 (without egg yolk antibody), control3 (without VP2 and egg yolk antibody), control4 (with BSA to replace VP2, or with Newcastle disease virus (NDV) to replace IBDV), and PBS was as background. S denotes scFv, N denotes control. NDV denotes IBDV was replaced by NDV.
Read Full Article HTML DOI: 10.29328/journal.aac.1001001 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."